Health

Health

Why online security is taxing our brains
Nathan Acosta is feeling a little overwhelmed. The 24-year-old from Raleigh, North Carolina, who works for a financial services firm, is trying his best to keep up with all the passwords and security questions he has to juggle, just to log onto his personal accounts. But sometimes it feels like a losing battle.

FDA asks experts if pain drugs get second chance
U.S. drug regulators are asking experts for advice on whether companies should restart clinical trials for painkillers that help people with osteoarthritis and other conditions, but can destroy joints. The U.S. Food and Drug Administration said these drugs, from the class of anti-nerve growth factors, represent a potentially significant and novel strategy for the treatment of pain," in a memo posted online on Thursday.
FDA rejects AstraZeneca move on generic Seroquel
Regulators have rejected a move by AstraZeneca that could have delayed the entry of generic versions of its top-selling antipsychotic Seroquel onto the U.S. market later this month. Britain's second biggest drugmaker said on Friday the Food and Drug Administration had denied its Citizen Petitions requesting the agency withhold finally approving any generic with labeling that did not have certain warning language required for its branded version.